Alpha-1 antitrypsin limits neutrophil extracellular trap disruption of airway epithelial barrier function

Kristin Hudock(Cincinnati Children's Hospital Medical Center), John P. Clancy(Cystic Fibrosis Foundation)

Frontiers in Immunology

January 10, 2023

10.3389/fimmu.2022.1023553

Cited by 18

Related Papers

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation

|New England Journal of Medicine|2010|802

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation

|Thorax|2011|496

CFTR modulator theratyping: Current status, gaps and future directions

|Journal of Cystic Fibrosis|2018|288

Myofibroblast Differentiation and Enhanced Tgf-B Signaling in Cystic Fibrosis Lung Disease

|PLoS ONE|2013|85

Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19

|JAMA Network Open|2023|17